Home » Newsletters » BioWorld Science

BioWorld Science

July 6, 2018

View Archived Issues

CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis

CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers

Serum netrin-1, a potential early biomarker for impaired fasting glucose and type 2 diabetes

NOVA2 or DDX6 mutations alter RNA metabolism leading to intellectual disability

[89]Zr-DFO-dinutuximab as novel radiotracer for selective detection of GD2-positive tumors

MR-438 peptidomimetic presented as a new radiosensitizing agent in medulloblastoma

Topline results announced from phase I study of ZYN-001 THC-prodrug patch

Expanded indication for Sprycel approved in Europe to include treatment of children with CP-CML

Safety review committee recommends continuation of phase Ib/II SENSITIZE study

Phase IIb study of LL-37 receives approval in Sweden

Vertex Pharmaceuticals presents new azoles for demyelinating diseases

Detection of NDMA in Zhejiang Huahai's valsartan leads to EMA review and product recall

Boehringer Ingelheim divulges SLC13A5 inhibitors

EMA validates Clovis' application for Rubraca as maintenance treatment for recurrent ovarian cancer

Icahn School of Medicine at Mount Sinai discloses PROTAc compounds for cancer

Nanjing TransThera Biosciences synthesizes protein kinase inhibitors for cancer

Zydus Cadila and CSIR-IMTECH collaborate to tackle drug-resistant infections

Medshine Discovery and collaborator patent CCR-2 and CCR-5 antagonists

Herantis initiates development program for noninvasive CDNF

Topline results from final analysis of phase II trial of BAN-2401 in Alzheimer's

MHRA approves Xonvea in U.K. for nausea and vomiting of pregnancy

Regulus Therapeutics announces corporate restructuring

Enzyvant partners with Visikol on digital pathology assay to support RVT-802

Takeda advances acquisition of TiGenix

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...